SUBSCRIPTION AGREEMENTSubscription Agreement • June 20th, 2014 • VG Life Sciences, Inc. • Pharmaceutical preparations • California
Contract Type FiledJune 20th, 2014 Company Industry JurisdictionThis Agreement shall constitute the irrevocable offer of the undersigned to purchase, in the amounts and subject to the terms set forth in this Agreement, one Convertible Debenture of Viral Genetics, Inc., a Delaware corporation (the "Company") ("Debenture"), with the face value of $50,000 in the form attached hereto as Exhibit A, for the purchase price of $50,000. On execution by both parties, this Agreement shall become a bilateral agreement binding on both the undersigned and the Company. Each part of this Agreement must be completed by the undersigned and, by execution below, the undersigned acknowledges that it understands that the Company is relying on the accuracy and completeness hereof in complying with its obligations under applicable securities laws.
SUBSCRIPTION AGREEMENTSubscription Agreement • June 20th, 2014 • VG Life Sciences, Inc. • Pharmaceutical preparations • California
Contract Type FiledJune 20th, 2014 Company Industry JurisdictionThis Agreement shall constitute the irrevocable offer of the undersigned to purchase,in the amounts and subject to the terms set forth in this Agreement, one Convertible Debenture of Viral Genetics, Inc., a Delaware corporation (the "Company") ("Debenture"), with the face value of $50000.00 in the form attached hereto as Exhibit A, for the purchase price of $50000.00. On execution by both parties, this Agreement shall become a bilateral agreement binding on both the undersigned and the Company. Each part of this Agreement must be completed by the undersigned and, by execution below, the undersigned acknowledges that it understands that the Company is relying on the accuracy and completeness hereof in complying with its obligations under applicable securities laws.